Massimo Levrero

23.6k total citations · 5 hit papers
246 papers, 16.9k citations indexed

About

Massimo Levrero is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Massimo Levrero has authored 246 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Epidemiology, 105 papers in Hepatology and 97 papers in Molecular Biology. Recurrent topics in Massimo Levrero's work include Hepatitis B Virus Studies (117 papers), Hepatitis C virus research (96 papers) and Liver Disease Diagnosis and Treatment (57 papers). Massimo Levrero is often cited by papers focused on Hepatitis B Virus Studies (117 papers), Hepatitis C virus research (96 papers) and Liver Disease Diagnosis and Treatment (57 papers). Massimo Levrero collaborates with scholars based in Italy, France and United States. Massimo Levrero's co-authors include Antonio Costanzo, Gioacchino Natoli, Clara Balsano, Jessica Zucman‐Rossi, Laura Belloni, Gerry Melino, Giovanni Raimondo, Natalia Pediconi, Teresa Pollicino and Francesca Guerrieri and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Massimo Levrero

241 papers receiving 16.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1999 785 citations Antonio Costanzo, Massimo Levrero et al. profile →
Mechanisms of HBV-induced hepatocellular carcinoma

2016 721 citations Massimo Levrero et al. Journal of Hepatology profile →
The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6)

1998 505 citations Gioacchino Natoli, Massimo Levrero et al. profile →
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

2012 444 citations Laura Belloni, Lena Allweiss et al. profile →
The scientific basis of combination therapy for chronic hepatitis B functional cure

2023 88 citations Massimo Levrero, Fabien Zoulim et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Levrero Italy	67	7.5k	7.5k	5.5k	4.1k	2.9k	246	16.9k
Kunitada Shimotohno Japan	74	8.5k 1.1×	7.8k 1.0×	10.4k 1.9×	1.4k 0.3×	4.7k 1.6×	355	21.8k
Eithan Galun Israel	57	2.5k 0.3×	5.0k 0.7×	2.0k 0.4×	2.9k 0.7×	3.0k 1.0×	206	12.6k
Stewart Sell United States	60	2.5k 0.3×	4.8k 0.6×	3.0k 0.5×	2.4k 0.6×	2.7k 0.9×	302	13.7k
Percy A. Knolle Germany	68	3.8k 0.5×	4.2k 0.6×	3.2k 0.6×	2.6k 0.6×	8.1k 2.8×	216	15.8k
Atsushi Miyajima Japan	84	1.9k 0.3×	10.3k 1.4×	3.3k 0.6×	8.7k 2.1×	10.2k 3.5×	364	26.6k
Paul J. Godowski United States	51	3.0k 0.4×	6.6k 0.9×	1.2k 0.2×	1.8k 0.4×	9.8k 3.4×	64	18.6k
Carl F. Ware United States	79	3.7k 0.5×	5.6k 0.7×	807 0.1×	4.4k 1.1×	13.4k 4.6×	257	21.3k
Riccardo Cortese Italy	60	2.9k 0.4×	5.7k 0.8×	2.7k 0.5×	849 0.2×	1.4k 0.5×	144	11.1k
Aleem Siddiqui United States	55	4.8k 0.6×	4.2k 0.6×	3.5k 0.6×	715 0.2×	1.1k 0.4×	106	9.3k
Sergio Abrignani Italy	60	4.6k 0.6×	2.6k 0.3×	5.3k 1.0×	996 0.2×	4.7k 1.6×	175	12.7k

Countries citing papers authored by Massimo Levrero

Since Specialization

Citations

This map shows the geographic impact of Massimo Levrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Levrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Levrero more than expected).

Fields of papers citing papers by Massimo Levrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Levrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Levrero. The network helps show where Massimo Levrero may publish in the future.

Co-authorship network of co-authors of Massimo Levrero

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Levrero. A scholar is included among the top collaborators of Massimo Levrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Levrero. Massimo Levrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Jihan, Estelle Pujos‐Guillot, Stéphanie Durand, et al.. (2025). Simultaneous Activation of Beta‐Oxidation and De Novo Lipogenesis in MASLD‐HCC: A New Paradigm. Liver International. 45(2). e70006–e70006. 5 indexed citations

Amblard, Franck, et al.. (2025). Functional immune responses induced by a capsid assembly modulator in chronic hepatitis B virus-infected humanized mice. Cell Host & Microbe. 34(1). 116–130.e7.

Baconnais, Sonia, Morgane Callon, Éric Le Cam, et al.. (2025). Structure and nucleic acid interactions of the S ^Δ60 domain of the hepatitis delta virus small antigen. Proceedings of the National Academy of Sciences. 122(19). e2411890122–e2411890122.

Plissonnier, Marie‐Laure, Xavier Grand, Hyosun Tak, et al.. (2024). A molecular standard for circulating HBV RNA detection and quantification assays in patients with chronic hepatitis B. JHEP Reports. 6(10). 101124–101124. 1 indexed citations

Caussy, Cyrielle, Bruno Vergès, Valérie Hervieu, et al.. (2024). WED-194 Diagnostic performance of non-invasive tests and comparison of AGA and EASL algorithm for the screening of MASLD-related advanced fibrosis in diabetes and nutrition clinics. Journal of Hepatology. 80. S508–S508.

Allweiss, Lena, Barbara Testoni, Yu Mei, et al.. (2023). Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 72(5). 972–983. 43 indexed citations

Fromentel, Claude Caron de & Massimo Levrero. (2020). p53 functional loss, stemness and hepatocellular carcinoma. Hepatoma Research. 2020. 9 indexed citations

Scopigno, T., et al.. (2016). The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells. Scientific Reports. 6(1). 28025–28025. 19 indexed citations

Testoni, Barbara, David Durantel, Fanny Lebossé, et al.. (2015). Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes. Gut. 65(4). 672–682. 13 indexed citations

10.

Belloni, Laura, et al.. (2013). 371 HAPS HEPATITIS B VIRUS (HBV) CAPSID INHIBITORS AFFECT CORE PROTEIN INTERACTION WITH THE MINICHROMOSOME AND TARGET cccDNA FUNCTION. Journal of Hepatology. 58. S153–S153. 3 indexed citations

11.

Belloni, Laura, Susana T. Valente, Dante Rotili, et al.. (2013). 56 SUPPRESSION OF HEPATITIS B VIRUS (HBV) TRANSCRIPTION AND REPLICATION BY SMALL MOLECULES THAT TARGET THE EPIGENETIC CONTROL OF NUCLEAR cccDNA MINICHROMOSOME. Journal of Hepatology. 58. S25–S25. 5 indexed citations

12.

Lefkimmiatis, Konstantinos, Mariano Francesco Caratozzolo, Paola Merlo, et al.. (2009). p73 and p63 Sustain Cellular Growth by Transcriptional Activation of Cell Cycle Progression Genes. Cancer Research. 69(22). 8563–8571. 34 indexed citations

13.

Belloni, Laura, et al.. (2009). 78 MODULATION OF THE EPIGENETIC REGULATION OF CCCDNA FUNCTION CONTRIBUTES TO IFNa INHIBITION OF HBV REPLICATION. Journal of Hepatology. 50. S32–S33. 1 indexed citations

14.

Weisz, Lilach, Alexander Damalas, Michalis Liontos, et al.. (2007). Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells. Cancer Research. 67(6). 2396–2401. 170 indexed citations

15.

Strano, Sabrina, Olimpia Monti, Natalia Pediconi, et al.. (2005). The Transcriptional Coactivator Yes-Associated Protein Drives p73 Gene-Target Specificity in Response to DNA Damage. Molecular Cell. 18(4). 447–459. 299 indexed citations

16.

Piccolella, Enza, Francesca Spadaro, Carlo Ramoni, et al.. (2003). Vav-1 and the IKKα Subunit of IκB Kinase Functionally Associate to Induce NF-κB Activation in Response to CD28 Engagement. The Journal of Immunology. 170(6). 2895–2903. 47 indexed citations

17.

Albertí, A., P.L. Almasio, Antonio Ascione, et al.. (1997). Guidelines for the treatment of chronic viral hepatitis. 29(6). 597–600. 4 indexed citations

18.

Artini, Marco, Clara Natoli, Nicola Tinari, et al.. (1996). Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients. Journal of Hepatology. 25(2). 212–217. 83 indexed citations

19.

Artini, Marco, Roberto Nisini, Gabriele Missale, et al.. (1995). Infection of Circulating and Liver Infiltrating T Cells by Hepatitis C Virus of Different Subtypes. Viral Immunology. 8(2). 63–73. 13 indexed citations

20.

Natoli, Gioacchino, Clara Balsano, Maria Laura Avantaggiati, et al.. (1992). Truncated pre-S/S proteins transactivate multiple target sequences. PubMed. 4. 65–69. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact